Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2002-02-28
2010-11-02
Weddington, Kevin (Department: 1614)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S274400, C546S278400, C546S280400, C546S283400, C546S287000, C546S307000
Reexamination Certificate
active
07825255
ABSTRACT:
The invention relates to the compounds of formula (I), to a method for producing the same and to the use thereof as medicaments.
REFERENCES:
patent: 7045632 (2006-05-01), Small
patent: 7078417 (2006-07-01), Rosentreter et al.
patent: 7109218 (2006-09-01), Rosentreter et al.
patent: 7135486 (2006-11-01), Rosentreter et al.
patent: 0125210 (2001-04-01), None
patent: 0162233 (2001-08-01), None
Kambe et al., “Synthetic Studies Using α,β-Unsaturated Nitriles: Facile Synthesis of Pyridine Derivatives”, Synthesis, vol. 7, pp. 531-533 (1981).
Olah, M.E. et al., “Cloning expression, and characterization of the unique bovine A1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis.” J. Biol. Chem. 267, 10764-10770, (1992).
Klotz, K.N. et al., “Comparative pharmacalogy of human adenosine receptor subtypes—characterization of stably transfected receptors in CHO Cells.” Naunyn Schmiedebergs Arch. Pharmacol. 357, 1-9, (1998).
Poulsen, S.A. et al., “Adeonosine Receptors: New Opportunities for Future Drugs”. Bioorganic and Medicinal Chem, 6, 619-641, (1998).
Broadley, K.J., “Drugs modulating adenosine receptors as potential therapeutic agents for cardiovascular diseases.” Exp. Opin. Ther. Patents, 10, 1669-1692 (2000).
Jacobson, K., van Galen, P., Williams, M., “Adenosine Receptors: Pharmacology, Structure-Activity Relationships, and Therapeutic Potential”, J. Med. Chem., 35(3): 407-422(1992).
Poulsen, S., Quinn, R., “Adenosine Receptors: New Opportunities for Future Drugs”, Bioorganic & Med. Chem., 6: 619-641(1998).
Dembowsky Klaus
Diedrichs Nicole
Hübsch Walter
Krahn Thomas
Krämer Thomas
Bayer Schering Pharma Aktiengesellschaft
DiCeglie, Jr. Nicholas J.
Edwards Angell Palmer & & Dodge LLP
Loren Ralph A.
Weddington Kevin
LandOfFree
Adenosine receptor selective modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adenosine receptor selective modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine receptor selective modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4160214